What’s interesting in cancer research right now? What do we most need to know about? This is the latest post in a series in which we review several of the most notable cancer research stories that have come out over the previous two to three months.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.
Topics covered this time include HER2-positive breast cancer, immune system therapies and overcoming treatment resistance.